Tuberculosis Drug Resistance: A Comprehensive Resource Database
Tuberculosis (TB) drug resistance presents a multifaceted and challenging issue in global health. Factors contributing to this complexity include inconsistent treatment regimens, incomplete medication courses, the spread of multidrug-resistant TB strains, and barriers to accessing quality healthcare. These issues are exacerbated in low and middle-income countries, where healthcare infrastructure and resources are often limited.
The AMR Knowledge Hub of The Global Health Network aims to address these challenges by building a robust database of resources dedicated to TB drug resistance. The goal is to connect researchers, healthcare professionals, and policymakers to vital information, tools, and studies that can inform and enhance TB drug resistance research and intervention efforts.
On this page, you will find links to a wealth of resources including working groups, guidelines, research papers, case studies, and educational videos. You can also access external resources that can further support your research and practice.
This page is continuously updated to reflect the latest advancements and findings in the field of TB drug resistance. Check back regularly for new information. If you have tools, documents, resources, or other items of interest that you believe would be valuable to share with the global TB research community, please contact the AMR Knowledge Hub by email . Let's advance the understanding and control of TB drug resistance together.
Click Below To Access Quick Read Collections
↓ World Health Organization (WHO) Resources
↓ Technical Reports and Guidelines
↓ Related Studies and Articles
↓ Additional Resources and Articles
Title
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
8 Things to Know about Drug-Resistant Tuberculosis
Drug-Resistant Tuberculosis: Implications for Transmission, Diagnosis, and Disease Management
Tuberculosis: Multidrug-Resistant (MDR-TB) or Rifampicin-Resistant TB (RR-TB)
Drug-Resistant Tuberculosis (Chapters and Articles)
Why Drug-Resistant Tuberculosis Poses a Major Risk to Global Health Security
25 Years of Surveillance of Drug-Resistant Tuberculosis: Achievements, Challenges, and Way Forward
Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017–2022
Drug-Resistant Tuberculosis: A Persistent Global Health Concern
Drug-Resistant Tuberculosis: A Review
Drug-Resistant Tuberculosis Responds Rapidly to Bedaquiline-based Second-Line Therapy
Global Prevalence of Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Drug Resistance: A Response to Antimicrobial Resistance Includes Tackling TB
Drug-Resistant TB
Drug-Resistant Tuberculosis
Report Warns of Rise in Drug-Resistant Tuberculosis
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa
Transmission of Multidrug-Resistant Mycobacterium Tuberculosis in Shanghai, China: A Retrospective Observational Study Using Whole-genome Sequencing and Epidemiological Investigation
Drug-Resistant Tuberculosis in 2017: At a Crossroads
The Epidemiology, Pathogenesis, Transmission, Diagnosis, and Management of Multidrug-Resistant, Extensively Drug-Resistant, and Incurable Tuberculosis
How to Treat Drug-Resistant Tuberculosis
A New Era for Treatment of Drug-Resistant Tuberculosis
Tuberculosis
Multidrug-Resistant Tuberculosis Cases, World (Multiple Data)
Multidrug-Resistant Tuberculosis
Criteria for the Control of Drug-Resistant Tuberculosis
World Health Organization Recommendations on the Treatment of Drug-Resistant Tuberculosis, 2020 Update
Multi-Drug Resistant Tuberculosis (MDR-TB)
Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
MDR TB Exposure Screening and Treatment Recommendations (PDF)
MDR Latent TB Infection Monitoring Flow Sheet (PDF)
Drug-Resistant Tuberculosis: A Survival Guide for Clinicians; UCSF
Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline, American Journal of Respiratory and Critical Care Medicine
Combating Multidrug-Resistant Tuberculosis: Year Five Report of the National Action Plan
↓ Global Tuberculosis Data Overview by Category
Category
Title
Mortality
Causes of death, World, 2021
Death rate from respiratory infectionsIHME, crude
Death rate from respiratory infectionsIHME, age-standardized
Deaths from respiratory infections
Estimated tuberculosis-related deaths among people living with HIV
Number of deaths from tuberculosisIHME
Number of deaths from tuberculosis and other diseases in people with HIV/AIDS
Tuberculosis death rate
Tuberculosis death rateIHME, age-standardized
Tuberculosis death rateWHO
Tuberculosis death rateIHME, crude
Tuberculosis death rate in people without HIVWHO, crude rate
Tuberculosis death rate, by ageIHME, by age group
Tuberculosis deathsWHO 2023
Tuberculosis deathsWHO GHE
Tuberculosis deaths by HIV status
Tuberculosis deaths by region
Tuberculosis deaths in children under five
Tuberculosis deaths, by age
Disease Epidemiology
Confirmed tuberculosis cases that are drug-resistant versus drug-susceptible
Global tuberculosis incidence rate, by age
Incidence and prevalence of extensively drug-resistant tuberculosis
Incidence of tuberculosisIHME
New cases of tuberculosis with uncertainty intervals
Number of people living with tuberculosis by drug susceptibility
Number of people with multidrug-resistant tuberculosis
Prevalence of extensively drug resistant tuberculosis
Rate of new tuberculosis cases
Share of the population estimated to have prior infection by Mycobacterium tuberculosis
Share of tuberculosis patients with HIV
Tuberculosis cases
Tuberculosis cases attributable to risk factors
Tuberculosis cases tested versus confirmed to be rifampicin resistant
Tuberculosis patients tested positive for HIV
Average cost of multi drug-resistant tuberculosis treatment
Average cost of tuberculosis treatment by type
Funding
Expected funding for tuberculosis versus required budget
Vaccination
Number of one-year-olds who are not vaccinated against tuberculosis
Number of one-year-olds who have received different vaccinations
Share of one-year-olds vaccinated against tuberculosis
Healthcare Infrastructure
Sites providing rapid tuberculosis diagnostics per million people
Treatment
Tuberculosis patients living with HIV receiving antiretroviral therapy
Tuberculosis treatment success rate
Tuberculosis treatment success rate by type